Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

HLA alleles and drug hypersensitivity reactions.

Profaizer T, Eckels D.

Int J Immunogenet. 2012 Apr;39(2):99-105. doi: 10.1111/j.1744-313X.2011.01061.x. Epub 2011 Dec 3. Review.

PMID:
22136512
2.

Human leukocyte antigens and drug hypersensitivity.

Chung WH, Hung SI, Chen YT.

Curr Opin Allergy Clin Immunol. 2007 Aug;7(4):317-23. Review.

PMID:
17620823
3.

[The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].

Wang Q, Mei H, Zhang YL, Pan XC, Tan W, Chao L.

Yao Xue Xue Bao. 2013 Jun;48(6):799-808. Review. Chinese.

PMID:
23984511
4.

Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.

Kaniwa N, Saito Y.

J Hum Genet. 2013 Jun;58(6):317-26. doi: 10.1038/jhg.2013.37. Epub 2013 May 2. Review.

PMID:
23635947
5.

Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.

Wei CY, Chung WH, Huang HW, Chen YT, Hung SI.

J Allergy Clin Immunol. 2012 Jun;129(6):1562-9.e5. doi: 10.1016/j.jaci.2011.12.990. Epub 2012 Feb 8.

PMID:
22322005
6.

Pharmacogenetics of cutaneous adverse drug reactions.

Aihara M.

J Dermatol. 2011 Mar;38(3):246-54. doi: 10.1111/j.1346-8138.2010.01196.x. Review.

PMID:
21342226
7.

Genotyping for severe drug hypersensitivity.

Karlin E, Phillips E.

Curr Allergy Asthma Rep. 2014 Mar;14(3):418. doi: 10.1007/s11882-013-0418-0. Review.

8.

T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction.

Ko TM, Chen YT.

Expert Rev Clin Immunol. 2012 Jul;8(5):467-77. doi: 10.1586/eci.12.31. Review.

PMID:
22882221
9.

Genetics and the potential for predictive tests in adverse drug reactions.

Pirmohamed M.

Chem Immunol Allergy. 2012;97:18-31. doi: 10.1159/000335613. Epub 2012 May 3.

PMID:
22613851
10.

[HLA-B*5701 and abacavir hypersensitivity reaction].

Servonnet A, Leclercq E, Delacour H, Ceppa F.

Pathol Biol (Paris). 2010 Dec;58(6):e95-100. doi: 10.1016/j.patbio.2008.12.001. Epub 2009 Feb 24. French.

PMID:
19243901
11.

Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.

Hsiao YH, Hui RC, Wu T, Chang WC, Hsih MS, Yang CH, Ho HC, Chang YG, Chen MJ, Lin JY, Chen DP, Chang PY, Wu TL, Hung SI, Chung WH.

J Dermatol Sci. 2014 Feb;73(2):101-9. doi: 10.1016/j.jdermsci.2013.10.003. Epub 2013 Oct 22.

PMID:
24268988
12.

HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions.

Ikeda H, Takahashi Y, Yamazaki E, Fujiwara T, Kaniwa N, Saito Y, Aihara M, Kashiwagi M, Muramatsu M.

Epilepsia. 2010 Feb;51(2):297-300. doi: 10.1111/j.1528-1167.2009.02269.x. Epub 2009 Aug 19.

13.

HLA-B*5701 screening for susceptibility to abacavir hypersensitivity.

Lucas A, Nolan D, Mallal S.

J Antimicrob Chemother. 2007 Apr;59(4):591-3. Epub 2007 Feb 22.

PMID:
17317695
14.

Pharmacogenetics of drug hypersensitivity.

Phillips EJ, Mallal SA.

Pharmacogenomics. 2010 Jul;11(7):973-87. doi: 10.2217/pgs.10.77. Review.

15.

Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status, and dose and treatment duration in paediatric neurology patients in Singapore.

Chong KW, Chan DW, Cheung YB, Ching LK, Hie SL, Thomas T, Ling S, Tan EC.

Arch Dis Child. 2014 Jun;99(6):581-4. doi: 10.1136/archdischild-2013-304767. Epub 2013 Nov 13.

PMID:
24225276
16.

HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.

Cheng CY, Su SC, Chen CH, Chen WL, Deng ST, Chung WH.

J Immunol Res. 2014;2014:565320. doi: 10.1155/2014/565320. Epub 2014 May 8. Review.

17.

[HLA-B*5701 and hypersensitivity reactions to abacavir. Study methods and clinical relevance].

Arnedo Valero M.

Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 6:34-9. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2008 Oct;26(8):536.

PMID:
18680694
18.

HLA-B*1502 screening in carbamazepine and lamotrigine candidates of Asian background.

Hassan I.

Aust N Z J Psychiatry. 2012 Nov;46(11):1106-7. doi: 10.1177/0004867412455702. Epub 2012 Jul 25. No abstract available.

PMID:
22833576
19.

Pharmacogenetic information derived from analysis of HLA alleles.

Gatanaga H, Honda H, Oka S.

Pharmacogenomics. 2008 Feb;9(2):207-14. doi: 10.2217/14622416.9.2.207. Review.

PMID:
18370849
20.

HLA and Delayed Drug-Induced Hypersensitivity.

Sousa-Pinto B, Correia C, Gomes L, Gil-Mata S, Ara├║jo L, Correia O, Delgado L.

Int Arch Allergy Immunol. 2016;170(3):163-79. doi: 10.1159/000448217. Epub 2016 Aug 26. Review.

PMID:
27576480

Supplemental Content

Support Center